In this study, we found RASSF10 was frequently silenced or down-regulated in HCC cell lines and HCC tissues as comparing with their adjacent non-tumor tissues, suggesting RASSF10 would be a potential tumor suppressor in the carcinogenesis of HCC. Here, RASSF10 is linked to neoplasm.